$ALT 3 SEC Filings

Filed On	Filing
02 Oct 2026	Form 3: Menziuso Richard Thomas, Principal Accounting Officer No securities owned
03 Oct 2025	Form 3: Arbet-Engels Christophe, Chief Medical Officer No securities owned
17 Sep 2025	Form 3: Richardson Linda M, Chief Commercial Officer No securities owned
26 Feb 2025	Form 3: Lawver Teri L, Director No securities owned
25 Feb 2025	Form 3: Durso Jerome Benedict, Director No securities owned
12 Nov 2024	Form 3: Weaver Gregory L, Chief Financial Officer No securities owned
01 Jul 2024	Form 3: Shutterly Andrew, See Remarks Holds 10,113 shares of Common Stock, par value $0.0001
27 Mar 2023	Form 3: Sohn Catherine A., Director No securities owned
04 Jan 2023	Form 3: Jordt Raymond M, Chief Business Officer No securities owned
04 Jan 2022	Form 3: Eisenstadt Richard I, Chief Financial Officer No securities owned
28 May 2020	Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 7 others Holds 1,696,364 shares of Common Stock
12 May 2020	Form 3: Jorkasky Diane, Director No securities owned
14 Feb 2020	Form 3: Velocity Pharmaceutical Holdings Llc, 10% owner and 3 others Holds 1,887,250 shares of Common Stock
11 Sep 2019	Form 3: Harris Matthew Scott, Chief Medical Officer No securities owned
04 Dec 2018	Form 3: Garg Vipin K, Director No securities owned
10 Sep 2018	Form 3: Pisano Wayne, Director No securities owned
31 May 2018	Form 3: Brown William Michael, Acting Chief Financial Officer No securities owned
15 May 2017	Form 3: Truffle Capital S.a.s., 10% owner Holds 416,043 shares of Common Stock, par value $0.0001
08 May 2017	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other Holds 1,867,301 shares of Common Stock, par value $0.0001
08 May 2017	Form 3: Enright William, Director No securities owned

Comments